Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)

CNY 6.3

(2.94%)

Market Cap (In CNY)

3.09 Billion

Revenue (In CNY)

890.71 Million

Net Income (In CNY)

-71.75 Million

Avg. Volume

11.92 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.58-8.97
PE
-63.0
EPS
-0.1
Beta Value
0.427
ISIN
CNE000001QK9
CUSIP
-
CIK
-
Shares
491947000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Xu Wang
Employee Count
-
Website
https://www.beilu.com.cn
Ipo Date
2009-10-30
Details
Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.